Product Details for: Veopoz
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous, Subcutaneous
400MG/2ML (200MG/ML)
Single-Dose Vial
351(a)
Veopoz
Rx
Proper Name
pozelimab-bbfg
pozelimab-bbfg
BLA Number
761339
761339
Applicant
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Original Approval Date
August 18, 2023
August 18, 2023
Date of First Licensure